CCL2 and neoplasm: Their recruitment to the tumors increases the interaction between estrogen receptors (ERs) and C–C Motif Chemokine Ligand 2 (CCL2), wherein CCL2 promotes epithelial-to-mesenchymal transition (EMT) and the production of matrix metalloproteinases (MMP) in the tumor location.